MétaCan
Menu
Back to cohort
Record W3016939709 · doi:10.1038/s41523-020-0156-0

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

2020· article· en· W3016939709 on OpenAlexaff
Zuzana Kos, Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen, Koen Van de Vijver, Shom Goel, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O. Nielsen, Sunil Badve, W. Fraser Symmans, Christos Sotiriou, David L. Rimm, Stephen M. Hewitt, Carsten Denkert, Sibylle Loibl, Stephen J. Luen, Peter Savas, Giancarlo Pruneri, Deborah Dillon, Maggie C.U. Cheang, Andrew Tutt, Jacqueline A. Hall, Marleen Kok, Hugo M. Horlings, Anant Madabhushi, Jeroen van der Laak, Francesco Ciompi, Anne‐Vibeke Lænkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H. Beck, J. Kaplan Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin T. Hiley, Maise Al Bakir, Alexander J. Lazar, Stephen P. Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria Vittoria Dieci, Fabrice André, Charles Swanton, Jorge S. Reis‐Filho, Joseph A. Sparano, Eva Balslev, I‐Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine L. Pogue–Geile, Kim Blenman, Frédérique Penault–Llorca, Stuart J. Schnitt, Sunil R. Lakhani, Anne Vincent‐Salomon, Federico Rojo, Jeremy Braybrooke, Matthew G. Hanna, María Teresa Soler-Monsó, Daniel Bethmann, Carlos Castaneda, Karen Willard‐Gallo, Ashish Sharma, Huang‐Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I. González-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David Moore, Roberto Salgado, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Allen M. Gown, Anna Sapino, André Moreira, Andrea L. Richardson, Andrea Vingiani, Andrew M. Bellizzi, Ángel Guerrero, Anita Grigoriadis, Ana C. Garrido-Castro, Ashley Cimino‐Mathews, Ashok Srinivasan, Balázs Ács, Baljit Singh, Benjamin C. Calhoun, Benjamin Haibe-Kans, Benjamin Solomon, Bibhusal Thapa, Brad H. Nelson, Carmen Ballesteroes-Merino, Carmen Criscitiello, Carolien Boeckx, Cécile Colpaert, Cecily Quinn, Chakra S. Chennubhotla, Cinzia Solinas, Damien Drubay, Dhanusha Sabanathan, Dieter Peeters, Dimitrios Zardavas, Doris Höflmayer, Douglas B. Johnson, E. Aubrey Thompson, Edith Perez, Ehab A. ElGabry, Elizabeth F. Blackley, Emily Reisenbichler, Ewa Chmielik, Fabien Gaire, Fang-I Lu, Farid Azmoudeh Ardalan, Franklin Peale, Fred R Hirsch, Gabriela Acosta-Haab, Gelareh Farshid, Glenn Broeckx, Harmut Koeppen, Harry R. Haynes, Heather L. McArthur, Heikki Joensuu, Helena Olofsson, Ian A. Cree, Iris Nederlof, Isabel Frahm, Iva Brčić, Jack Junjie Chan, James Ziai, Jane Brock, Jelle Weseling, Jennifer M. Giltnane, Jérôme Lemonnier, Jiping Zha, Joana Ribeiro, Jochen K. Lennerz, Jodi M. Carter, Johan Hartman, Johannes A. Hainfellner, John Le Quesne, Jonathan Juco, José van den Berg, Joselyn Sanchez, Joël Cucherousset, Julien Adam, Justin M. Balko, Kai Saeger, Kalliopi P. Siziopikou, Karolina Sikorska, Karsten E. Weber, Keith E. Steele, Kenneth Emancipator, Khalid El Bairi, Kimberly H. Allison, Konstanty Korski, Laurence Buisseret, Leming Shi, Loes Kooreman, Luciana Molinero, Mónica V. Estrada, Maartje van Seijen, Magali Lacroix‐Triki, Manu Sebastian, Marcelo Luiz Balancin, Marie‐Christine Mathieu, Marc J. van de Vijver, Marlon C. Rebelatto, Martine Piccart, Matthew P. Goetz, Matthias Preusser, Mehrnoush Khojasteh, Melinda E. Sanders, Meredith M. Regan, Michael Barnes, Michael Christie, Michael J. Misialek, Michail Ignatiadis, Michiel de Maaker, Mieke Van Bockstal, Nadia Harbeck, Nadine Tung, Nele Laudus, Nicolas Sirtaine, Nicole Burchardi, Nils Ternès, Nina Radosevic‐Robin, Oleg Gluz, Oliver Grimm, Paolo Nucíforo, Paul Jank, Pawan Kirtani, Peter H. Watson, Peter Jelinic, Prudence A. Francis, Prudence A. Russell, Robert H. Pierce, Robert K. Hills, Roberto A. Leon‐Ferre, Roland de Wind, Ruohong Shui, Samuel Leung, Sami Tabbarah, Sandra C. Souza, Sandra A. O’Toole, Sandra M. Swain, Sarah Dudgeon, Scooter Willis, Scott Ely, Shahinaz Bedri, Sheeba Irshad, Shiwei Liu, Shona Hendry, Simonetta Bianchi, Sofia Bragança, Soonmyung Paik, Sua Luz, Thomas Gevaert, Timothy d’Alfons, Tomohagu Sugie, Uday Kurkure, Veerle Bossuyt, Venkata Manem, Vincente Peg Cámaea, Weida Tong, William T. Tran, Yihong Wang, Yves Allory, Zaheed Husain, Zsuzsanna Bagó-Horváth

Bibliographic record

Venuenpj Breast Cancer · 2020
Typearticle
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsHealth Sciences CentreSunnybrook Health Science CentreUniversity of British ColumbiaSpinal Cord Injury BCNational Circus SchoolOntario Institute for Cancer ResearchPrincess Margaret Cancer CentreBC Cancer Agency
FundersNational Center for Research ResourcesDaiichi Sankyo EuropeNational Cancer InstituteMedical Research CouncilStand Up To CancerNational Institutes of HealthRosetrees TrustCRUK Lung Cancer Centre of ExcellenceNational Institute for Health and Care ResearchUniversity College LondonWellcome TrustCancer Research UKWallace H. Coulter FoundationMyriad GeneticsFrancis Crick InstituteGeorgia Clinical and Translational Science AllianceSusan G. KomenProstate Cancer FoundationAstraZenecaU.S. Department of DefenseEli Lilly and CompanyCase Western Reserve UniversityNational Breast Cancer FoundationU.S. Department of Veterans AffairsBreast Cancer AlliancePfizerAmgenEuropean CommissionDOD Peer Reviewed Cancer Research ProgramBreast Cancer Research Foundation
KeywordsBreast cancerCancerMedicineStromal cellBreast tumorPathologyStromal tumorOncologyInternal medicine

Abstract

fetched live from OpenAlex

Stromal tumor-infiltrating lymphocytes (sTILs) are important prognostic and predictive biomarkers in triple-negative (TNBC) and HER2-positive breast cancer. Incorporating sTILs into clinical practice necessitates reproducible assessment. Previously developed standardized scoring guidelines have been widely embraced by the clinical and research communities. We evaluated sources of variability in sTIL assessment by pathologists in three previous sTIL ring studies. We identify common challenges and evaluate impact of discrepancies on outcome estimates in early TNBC using a newly-developed prognostic tool. Discordant sTIL assessment is driven by heterogeneity in lymphocyte distribution. Additional factors include: technical slide-related issues; scoring outside the tumor boundary; tumors with minimal assessable stroma; including lymphocytes associated with other structures; and including other inflammatory cells. Small variations in sTIL assessment modestly alter risk estimation in early TNBC but have the potential to affect treatment selection if cutpoints are employed. Scoring and averaging multiple areas, as well as use of reference images, improve consistency of sTIL evaluation. Moreover, to assist in avoiding the pitfalls identified in this analysis, we developed an educational resource available at www.tilsinbreastcancer.org/pitfalls.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.049
metaresearch head score (Gemma)0.072
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.049
Threshold uncertainty score0.261

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0490.072
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0030.002
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.301
Teacher spread0.281 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations206
Published2020
Admission routes1
Has abstractyes

Explore more

Same venuenpj Breast CancerSame topicCancer Immunotherapy and BiomarkersFrench-language works237,207